Trial intelligence / Profile preview

TSR-011 in advanced solid tumors and lymphomas

NCT02048488Phase 2Completed

Start
Oct 2012
Primary completion
Sep 2016
Modality
Small Molecules
Countries
5
01

Overview

A Phase 2 trial of belizatinib in solid tumor, lymphoma. Started Oct 2012; status: completed.

02

Drugs

belizatinib
03

Conditions

solid tumorlymphoma

Beyond the preview

Go deeper on NCT02048488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02048488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call